Antibiotics/antimicrobials: Systemic and local administration in the therapy of mild to moderately advanced periodontitis

Periodontology 2000

Volumn 71, Issue 1, 2016, Pages 82-112

  Jepsen, Karin ^a   Jepsen, Søren ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

CHRONIC PERIODONTITIS; DISINFECTION; HUMAN; META ANALYSIS (TOPIC); MICROBIOLOGY; PERIODONTITIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHRONIC PERIODONTITIS; DISINFECTION; HUMANS; META-ANALYSIS AS TOPIC; PERIODONTITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84962168804     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/prd.12121     Document Type: Review

References (241)

1. American Academy of Periodontology Task Force Report on the update to the 1999 Classification of Periodontal Diseases and Conditions. J Periodontol 2015: 86: 835-838.
2. Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. J Clin Periodontol 2012: 39: 284-294.
3. Aimetti M, Romano F, Torta I, Cirillo D, Caposio P, Romagnoli R. Debridement and local application of tetracycline-loaded fibres in the management of persistent periodontitis: results after 12 months. J Clin Periodontol 2004: 31: 166-172.
4. Akalin FA, Baltacioglu E, Sengün D, Hekimoglu S, Taskin M, Etikan I, Fisenk I. A comparative evaluation of the clinical effects of systemic and local doxycycline in the treatment of chronic periodontitis. J Oral Sci 2004: 46: 25-35.
5. Al-Joburi W, Quee TC, Lautar C, Iugovaz I, Bourgouin J, Delorme F, Chan ECS. Effects of adjunctive treatment of periodontitis with tetracycline and spiramycin. J Periodontol 1989: 60: 533-539.
6. Aminov RI. The role of antibiotics and antibiotic resistance in nature. Environ Microbiol 2009: 11: 2970-2988.
7. Angaji M, Gelskey S, Nogueira-Filho G, Brothwell D. A systematic review of clinical efficacy of adjunctive antibiotics in the treatment of smokers with periodontitis. J Periodontol 2010: 81: 1518-1528.
8. Antunes LCM, Han J, Ferreira RBR, Lolic P, Borchers CH, Finlay BB. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 2011: 55: 1494-1503.
9. Ardila CM, Granada MI, Guzmán IC. Antibiotic resistance of subgingival species in chronic periodontitis patients. J Periodontal Res 2010: 45: 557-563.
10. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 2000: 4: 1-6.
11. Armitage GC. Learned and unlearned concepts in periodontal diagnostics: a 50-year perspective. Periodontol 2000 2013: 62: 20-36.
12. Azmak DN, Atilla G, Luoto H, Sorsa T. The effect of subgingival controlled-release delivery of chlorhexidine chip onclinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fluid. J Periodontol 2002: 73: 603-615.
13. Baltacioglu E, Aslan M, Sarac O, Saybak A, Yuva P. Analysis of clinical results of systemic antimicrobials combined with nonsurgical periodontal treatment for generalized aggressive periodontitis: a pilot study. J Can Dent Assoc 2011: 77: b97.
14. Baquero F. Metagenomic epidemiology: a public health need for the control of antimicrobial resistance. Clin Microbiol Infect 2012: 18: 67-73.
15. Becker W, Becker BE, Ochsenbein C, Kerry G, Caffesse R, Morrison EC, Prichard J. A Longitudinal study comparing scaling, osseous surgery and modified Widman procedures. J Periodontol 1987: 59: 351-365.
16. Belda-Ferre P, Alcaraz LD, Cabrera-Rubio R, Romero H, Simón-Soro A, Pignatelli M, Mira A. The oral metagenome in health and disease. ISME J 2011: 6: 46-56.
17. Bergström J. Tobacco smoking and risk for periodontal disease. J Clin Periodontol 2003: 30: 107-113.
18. Blaser M. Antibiotic overuse: stop the killing of beneficial bacteria. Nature 2011: 476: 393-394.
19. Bogren A, Teles RP, Torresyap G, Haffajee AD, Socransky SS, Wennstrom JL. Locally delivered doxycycline during supportive periodontal therapy: a 3-year study. J Periodontol 2008: 79: 827-835.
20. Bonito DAJ, Lux L, Lohr KN. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol 2005: 76: 1227-1236.
21. Boyton RJ, Reynolds CJ, Quigley KJ, Altmann DM. Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis. Clin Exp Immunol 2013: 171: 117-123.
22. Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol 2014: 26: 101-107.
23. Cahenzli J, Köller Y, Wyss M, Geuking MB, McCoy KD. Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe 2013: 14: 559-570.
24. Cani PD. Gut microbiota and obesity: lessons from the microbiome. Brief Funct Genomics 2013: 12: 381-387.
25. Caricilli A, Saad M. The role of gut microbiota on insulin resistance. Nutrients 2013: 5: 829-851.
26. Carlet J. World alliance against antibiotic resistance: the WAAAR declaration against antibiotic resistance. Med Intensiva 2014: 39: 34-39; http://dx.doi.org/10.1016/j.medin.2014.10.004.
27. Carvalho J, Novak MJ, Mota LF. Evaluation of the effect of subgingival placement of chlorhexidine chips as an adjunct to scaling and root planing. J Periodontol 2007: 78: 997-1001.
28. Casarin RC, Peloso Ribeiro ED, Sallum EA, Nocviti FH Jr, Gonçalves RB, Casati MZ. The combination of amoxicillin and metronidazole improves clinical and microbiologic results of one-stage, full-mouth, ultrasonic debridement in aggressive periodontitis treatment. J Periodontol 2012: 83: 988-998.
29. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, Young VB. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008: 197: 435-438.
30. Chassaing B, Gewirtz AT. Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol Pathol 2014: 42: 49-53.
31. Cionca N, Giannopoulou C, Ugolotti G, Mombelli A. Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis. J Periodontol 2009: 80: 364-371.
32. Cionca N, Giannopoulou C, Ugolotti G, Mombelli A. Microbiologic testing and outcomes of full-mouth scaling and root planing with or without amoxicillin/metronidazole in chronic periodontitis. J Periodontol 2010: 81: 15-23.
33. Citorik RJ, Mimee M, Lu TK. Bacteriophage-based synthetic biology for the study of infectious diseases. Curr Opin Microbiol 2014: 19: 59-69.
34. Cobb CM. Non-surgical pocket therapy. Ann Periodontol 1996: 1: 443-490.
35. Cobb CM. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol 2002: 29(Suppl 2): 6-16.
36. Costello EK, Stagaman K, Dethlefsen L, Bohannan B, Relman DA. The application of ecological theory towards an understanding of the human microbiome. Science 2012: 336: 1255-1262.
37. Cosyn J, Wyn I, De Rouck T, Sabzevar MM. A chlorhexidine varnish implemented treatment strategy for chronic periodontitis. J Clin Periodontol 2005: 32: 750-756.
38. Cosyn J, Wyn I, De Rouck T, Sabzevar MM. Clinical benefits of subgingival chlorhexidine varnish application as an adjunct to same-day full-mouth root planing: a pilot study. J Periodontol 2006: 77: 1074-1079.
39. Cosyn J, Wyn I, De Rouck T, Sabzevar MM. Subgingival chlorhexidine varnish administration as an adjunct to same-day full-mouth root planing. I. clinical observations. J Periodontol 2007: 78: 430-437.
40. Cugini MA, Haffajee AD, Smith C, Kent RL, Socransky SS. The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results. J Clin Periodontol 2000: 27: 30-36.
41. Dannewitz B, Pohl S, Eickholz P, Kim TS. Clinical and microbiological effects of a combined mechanic-antibiotic therapy in subjects with Actinobacillus actinomycetemcomitans-associated periodontitis. Am J Dent 2007: 20: 153-156.
42. Dantas G, Sommer M, Oluwasegun RD, Church GM. Bacteria subsisting on antibiotics. Science 2008: 320: 100-103.
43. Darby IB, Hodge PJ, Riggio MP, Kinane DF. Clinical and microbiological effect of scaling and root planing in smoker and non-smoker chronic and aggressive periodontitis patients. J Clin Periodontol 2005: 32: 200-206.
44. D'Costa VM, King CE, Kalan L, Morar M, Sung WWL, Schwarz C, Froese D, Zazula G, Calmels F, Debruyne R, Golding GB, Poinar HN, Wright GD. Antibiotic resistance is ancient. Nature 2011: 477: 457-461.
45. Delhaes L, Monchy S, Fréalle E, Hubans C, Salleron J, Leroy S, Prevotat A, Wallet F, Wallaert B, Dei-Cas E, Sime-Ngando T, Chabé M, Viscogliosi E. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community - implications for therapeutic management. PLoS ONE 2012: 7: e36313.
46. Dethlefsen L, Relman DA. Colloquium paper: incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011: 108: 4554.
47. Dommisch H, Jepsen S. Diverse functions of defensins and other antimicrobial peptides in periodontal tissues. Periodontol 2000 2015: 69: 96-110.
48. Drisko CL. Nonsurgical periodontal therapy. Periodontol 2000 2001: 25: 77-88.
49. Drisko CL. Periodontal debridement: still the treatment of choice. J Evid Based Dent Pract 2014: 14: 33-41.e1.
50. Dumas ME, Kinross J, Nicholson JK. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. Gastroenterology 2014: 146: 46-62.
51. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011: 8: 523-531.
52. Ehmke B, Beikler T, Haubitz I, Karch H, Flemmig TF. Multifactorial assessment of predictors for prevention of periodontal disease progression. Clin Oral Investig 2003: 7: 217-221.
53. Ehmke DB, Moter A, Beikler T, Milian E, Flemmig TF. Adjunctive antimicrobial therapy of periodontitis: long-term effects on disease progression and oral colonization. J Periodontol 2005: 76: 749-759.
54. Eick S, Pfister W. Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study. J Periodontol 2004: 75: 1327-1334.
55. Eickholz P, Kim T-S, Burklin T, Schacher B, Renggli HH, Schaecken MT, Holle R, Kubler A, Ratka-Krüger P. Non-surgical periodontal therapy with adjunctive topical doxycycline: a double-blind randomized controlled multicenter study. (I). Study design and clinical results. J Clin Periodontol 2002: 29: 108-117.
56. Ellen RP, McCulloch CAG. Evidence versus empiricism: rational use of systemic antimicrobial agents for treatment of periodontitis. Periodontol 2000 1996: 10: 29-44.
57. Feres M, Faveri M, Figueiredo LC, Teles R, Flemmig T, Williams R, Lang NP. Group B initiator paper non-surgical periodontal therapy: mechanical debridement, antimicrobial agents and other modalities. J Int Acad Periodontol 2014: 17: s1-s10.
58. Feres M, Figueiredo LC, Silva Soares GM, Faveri M. Systemic antibiotics in the treatment of periodontitis. Periodontol 2000 2015: 67: 131-186.
59. Feres M, Soares GMS, Mendes JAV, Silva MP, Faveri M, Teles R, Socransky SS, Figueiredo LC. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol 2012: 39: 1149-1158.
60. Finkelman RD, Polson AM. Evidence-based considerations for the clinical use of locally delivered, controlled-release antimicrobials in periodontal therapy. J Dent Hyg 2013: 87: 249-264.
61. Flemmig TF, Milián E, Karch H, Klaiber B. Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis. J Clin Periodontol 1998: 25: 380-387.
62. Forslund K, Sunagawa S, Coelho LP, Bork P. Metagenomic insights into the human gut resistome and the forces that shape it. BioEssays 2014: 36: 316-329.
63. Franzosa EA, Huang K, Meadow JF, Gevers D, Lemon KP, Bohannan B, Huttenhower C. Identifying personal microbiomes using metagenomic codes. PNAS 2015: 112: E2930-8. www.pnas.org-cgi-doi-10.1073-pnas.1423854112.
64. Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 2013: 63: 149-164.
65. Friesen LR, Williams KB, Krause LS, Killoy WJ. Controlled local delivery of tetracycline with polymer strips in the treatment of periodontitis. J Periodontol 2002: 73: 13-19.
66. Garcia Canas P, Khouly I, Sanz J, Loomer PM. Effectiveness of systemic antimicrobial therapy in combination with scaling and root planing in the treatmentof periodontitis. J Am Dent Assoc 2015: 146: 150-163.
67. Glowacki AJ, Yoshizawa S, Timmerman MF. Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes. Proc Natl Acad Sci USA 2013: 110: 18525-18530.
68. Gonzaga-Jauregui C, Lupski JR, Gibbs RA. Human genome sequencing in health and disease. Annu Rev Med 2012: 63: 35-61.
69. Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000 1994: 5: 142-168.
70. Goodson JM, Gunsolley JC, Grossi SG, Bland PS, Otomo-Corgel J, Doherty F, Comiskey J. Minocycline HCl microspheres reduce red-complex bacteria in periodontal disease therapy. J Periodontol 2007: 78: 1568-1579.
71. Goodson JM, Haffajee AD, Socransky SS, Kent R, Teles R, Hasturk H, Bogren A, Van Dyke T, Wennström J, Lindhe J. Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. J Clin Periodontol 2012: 39: 526-536.
72. Gordon JI, Dewey KG, Mills DA, RM F. The human gut microbiota and undernutrition. Sci Transl Med 2012: 4: 1-6.
73. Graça MA, Watts TL, Wilson RF, Palmer RM. A randomized controlled trial of a 2% minocycline gel as an adjunct to non-surgical periodontal treatment, using a design with multiple matching criteria. J Clin Periodontol 1997: 24: 249-253.
74. Gregory JC, Buffa JA, Org E, Wang Z, Levison BS, Zhu W, Wagner MA, Bennett BJ, Li L, DiDonato JA, Lusis AJ, Hazen SL. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem 2015: 290: 5647-5660.
75. Grice EA, Segre JA. The human microbiome: our second genome. Annu Rev Genomics Hum Genet 2012: 13: 151-170.
76. Griffiths GS, Ayob R, Guerrero A, Nibali L, Suvan J, Moles DR, Tonetti MS. Amoxicillin and metronidazole as an adjunctive treatment in generalized aggressive periodontitis at initial therapy or re-treatment: a randomized controlled clinical trial. J Clin Periodontol 2011: 38: 43-49.
77. Grisi DC, Salvador SL, Figueiredo LC, Souza SLS, Novaes AB, Grisi MFM. Effect of a controlled-release chlorhexidine chip on clinical and microbiological parameters of periodontal syndrome. J Clin Periodontol 2002: 29: 875-881.
78. Grossi SG, Goodson JM, Gunsolley JC, Otomo-Corgel J, Bland PS, Doherty F, Comiskey J. Mechanical therapy with adjunctive minocycline microspheres reduces red-complex bacteria in smokers. J Periodontol 2007: 78: 1741-1750.
79. Guerrero A, Echeverría JJ, Tonetti MS. Incomplete adherence to an adjunctive systemic antibiotic regimen decreases clinical outcomes in generalized aggressive periodontitis patients: a pilot retrospective study. J Clin Periodontol 2007: 34: 897-902.
80. Guerrero A, Griffiths GS, Nibali L, Suvan J, Moles DR, Laurell L, Tonetti MS. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 2005: 32: 1096-1107.
81. Güntsch A, Erler M, Preshaw PM, Sigusch BW, Klinger G, Glockmann E. Effect of smoking on crevicular polymorphonuclear neutrophil function in periodontally healthy subjects. J Periodontal Res 2006: 41: 184-188.
82. Guo L, McLean JS, Yang Y, Eckert R, Kaplan CW, Kyme P, Sheikh O, Varnum B, Lux R, Shi W, He X. Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology. Proc Natl Acad Sci USA 2015: 112: 7569-7574.
83. Gupta R, Pandit N, Aggarwal S, Verma A. Comparative evaluation of subgingivally delivered 10% doxycycline hyclate and xanthan-based chlorhexidine gels in the treatment of chronic periodontitis. J Contemp Dent Pract 2008: 9: 25-32.
84. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003: 8: 115-181.
85. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 2015: 15: 30-44.
86. Hanes PJ, Purvis JP. Local anti-infective therapy: pharmacological agents. A systematic review. Ann Periodontol 2003: 8: 79-98.
87. Harks I, Koch R, Eickholz P, Hoffmann T, Kim T-S, Kocher T, Meyle J, Kaner D, Schlagenhauf U, Doering S, Holtfreter B, Gravemeier M, Harmsen D, Ehmke B. Is progression of periodontitis relevantly influenced by systemic antibiotics? A clinical randomized trial. J Clin Periodontol 2015: 42: 832-842.
88. Hasturk H, Abdallah R, Kantarci A, Nguyen D, Giordano N, Hamilton J, Van Dyke TE. Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis. Arterioscler Thromb Vasc Biol 2015: 4: 1-12.
89. Haubek D, Johansson A. Pathogenicity of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans and its geographic dissemination and role in aggressive periodontitis. J Oral Microbiol 2014: 6: 1.
90. Heasman PA, Heasman L, Stacey F, McCracken GI. Local delivery of chlorhexidine gluconate (PerioChip) in periodontal maintenance patients. J Clin Periodontol 2001: 28: 90-95.
91. Heasman L, Stacey F, Preshaw PM, McCracken GI, Hepburn S, Heasman PA. The effect of smoking on periodontal treatment response: a review of clinical evidence. J Clin Periodontol 2006: 33: 241-253.
92. Heller D, Varela VM, Silva-Senem MXE, Torres MCB, Feres-Filho EJ, Colombo APV. Impact of systemic antimicrobials combined with anti-infective mechanical debridement on the microbiota of generalized aggressive periodontitis: a 6-month RCT. J Clin Periodontol 2011: 38: 355-364.
93. Henderson RJ, Boyens JV, Holborow DW, Pack ARC. Scaling and root-planing treatment with adjunctive subgingival minocycline. A clinical pilot study over six months, of sites adjacent to and remote from the antibiotic application. J Int Acad Periodontol 2002: 4: 77-87.
94. Herrera D, Alonso B, León R, Roldán S, Sanz M. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol 2008: 35: 45-66.
95. Herrera D, Matesanz P, Bascones-Martinez DA, Sanz M. Local and systemic antimicrobial therapy in periodontics. J Evid Based Dent Pract 2012: S1: 50-60.
96. Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002: 29(Suppl 3): 136-159.
97. Hirsch R, Deng H, Laohachai MN. Azithromycin in periodontal treatment: more than an antibiotic. J Periodontal Res 2011: 47: 137-148.
98. Höglund-Aberg C, Kwamin F, Claesson R, Dahlén G, Johansson A, Haubek D. Progression of attachment loss is strongly associated with presence of the JP2 genotype of Aggregatibacter actinomycetemcomitans: a prospective cohort study of a young adolescent population. J Clin Periodontol 2014: 41: 232-241.
99. Huang YJ, Boushey HA. The Microbiome and asthma. Ann Am Thorac Soc 2014: 11: S48-S51.
100. Hung H-C, Douglass CW. Meta-analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss. J Clin Periodontol 2002: 29: 975-986.
101. Jarrold CR, Allaker RP, Young KA, Heath MR, Hardie JM, Lynch E. Clinical and microbiological effects of topical minocycline in the treatment of elderly patients with periodontitis. Br Dent J 1997: 183: 51-56.
102. Jeffcoat MK, Bray KS, Ciancio SG, Dentino AR, Fine DH, Gordon JM, Gunsolley JC, Killoy WJ, Lowenguth RA, Magnusson NI, Offenbacher S, Palcanis KG, Proskin HM, Finkelman RD, Flashner M. Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone. J Periodontol 1998: 69: 989-997.
103. Jeffcoat MK, Palcanis KG, Weatherford TW, Reese M, Geurs NC, Flashner M. Use of a biodegradable chlorhexidine chip in the treatment of adult periodontitis: clinical and radiographic findings. J Periodontol 2000: 71: 256-262.
104. Jepsen S, Deschner J, Braun A, Schwarz F, Eberhard J. Calculus removal and the prevention of its formation. Periodontol 2000 2011: 55: 167-188.
105. Jepsen K, Jaeger A, Jepsen S. Esthetic and functional rehabilitation of a severely compromised central incisor: an interdisciplinary approach. Int J Periodontics Restorative Dent 2015: 35: e35-e43.
106. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010: 156: 3216-3223.
107. Johnson JD, Chen R, Lenton PA, Zhang G, Hinrichs JE, Rudney JD. Persistence of extracrevicular bacterial reservoirs after treatment of aggressive periodontitis. J Periodontol 2008: 79: 2305-2312.
108. Johnson GK, Guthmiller JM. The impact of cigarette smoking on periodontal disease and treatment. Periodontol 2000 2007: 44: 178-194.
109. Jones AA, Kornman KS, Newbold DA, Manwell MA. Clinical and microbiological effects of controlled-release locally delivered minocycline in periodontitis. J Periodontol 1994: 65: 1058-1066.
110. Kasaj A, Chiriachide A, Willershausen B. The adjunctive use of a controlled-release chlorhexidine chip following treatment with a new ultrasonic device in supportive periodontal therapy: a prospective, controlled clinical study. Int J Dent Hyg 2007: 5: 225-231.
111. Kaur N, Chen C-C, Luther J, Kao JY. Intestinal dysbiosis in inflammatory bowel disease. Gut Microbes 2014: 2: 211-216.
112. Keestra JAJ, Grosjean I, Coucke W, Quirynen M, Teughels W. Non-surgical periodontal therapy with systemic antibiotics in patients with untreated aggressive periodontitis: a systematic review and meta-analysis. J Periodontal Res 2014: 50: 689-706.
113. Keestra JAJ, Grosjean I, Coucke W, Quirynen M, Teughels W. Non-surgical periodontal therapy with systemic antibiotics in patients with untreated chronic periodontitis: a systematic review and meta-analysis. J Periodontal Res 2014: 50: 294-314.
114. Killoy WJ. The clinical significance of local chemotherapies. J Clin Periodontol 2002: 29(Suppl 2): 22-29.
115. Kinane DF, Radvar M. The effect of smoking on mechanical and antimicrobial periodontal therapy. J Periodontol 1997: 68: 467-472.
116. Kinane DF, Radvar M. A six-month comparison of three periodontal local antimicrobial therapies in persistent periodontal pockets. J Periodontol 1999: 70: 1-7.
117. Kleiman SC, Carroll IM, Tarantino LM, Bulik CM. Gut feelings: a role for the intestinal microbiota in anorexia nervosa? Int J Eat Disord 2015: 48: 449-451.
118. Knapp CW, Dolfing J, Ehlert PAI, Graham DW. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ Sci Technol 2010: 44: 580-587.
119. Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract 2012: 27: 201-214.
120. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI. Evolution of mammals and their gut microbes. Science 2008: 320: 1647-1651.
121. de Lima Oliveira AP, de Faveri M, Gursky LC, Mestnik MJ, Feres M, Haffajee AD, Socransky SS, Teles RP. Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects. J Clin Periodontol 2012: 39: 295-302.
122. Lindhe J, Westfelt E, Nyman S, Socransky SS, Heijl L, Bratthall G. Healing following surgical/non-surgical treatment of periodontal disease. A clinical study. J Clin Periodontol 1982: 9: 115-128.
123. Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, Mueller A, Schäberle TF, Hughes DE, Epstein S, Jones M, Lazarides L, Steadman VA, Cohen DR, Felix CR, Fetterman KA, Millett WP, Nitti AG, Zullo AM, Chen C, Lewis K. A new antibiotic kills pathogens without detectable resistance. Nature 2015: 517: 455-459.
124. Loesche WJ, Giordani JR, Soehren S, Karciroti M. The nonsurgical treatment of patients with periodontal disease: results after five years. J Am Dent Assoc 2002: 133: 311-320.
125. Loesche WJ, Giordano M, Hujuel PP, Schwarez J, Smith BA. Metronidazole in periodontitis: reduced need for surgery. J Clin Periodontol 1992: 19: 103-112.
126. Loesche WJ, Schmidt E, Smith BA, Timmerman MF. Effects of metronidazole on periodontal treatment needs. J Periodontol 1991: 62: 247-257.
127. Machion L, Andia DC, Lecio G, Nociti FH, Casati MZ, Sallum AW, Sallum EA. Locally delivered doxycycline as an adjunctive therapy to scaling and root planing in the treatment of smokers: a 2-year follow-up. J Periodontol 2006: 77: 606-613.
128. Manček-Keber M, Frank-Bertoncelj M, Hafner-Bratkovič I, Smole A, Zorko M, Pirher N, Hayer S, Kralj-Iglič V, Rozman B, Ilc N, Horvat S, Jerala R. Toll-like receptor 4 senses oxidative stress mediated by the oxidation of phospholipids in extracellular vesicles. Sci Signal 2015: 8: ra60.
129. Marsh PD. Dental plaque: biological significance of a biofilm and community life-style. J Clin Periodontol 2011: 32: 7-15.
130. Marsh PD, Moter A, Devine DA. Dental plaque biofilms: communities, conflict and control. Periodontol 2000 2010: 55: 16-35.
131. Mascarenhas P, Gapski R, Al-Shammari K, Hill R, Soehren S, Fenno JC, Giannobile WV, Wang DH-L. Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers. J Periodontol 2005: 76: 426-436.
132. Matarazzo F, Figueiredo LC, Cruz SEB, Faveri M, Feres M. Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol 2008: 35: 885-896.
133. Matesanz-Pérez P, García-Gargallo M, Figuero E, Bascones-Martínez A, Sanz M, Herrera D. A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis. J Clin Periodontol 2013: 40: 227-241.
134. Matuliene G, Pjetursson BE, Salvi GE, Schmidlin K, Bragger U, Zwahlen M, Lang NP. Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. J Clin Periodontol 2008: 35: 685-695.
135. Meinberg TA, Barnes CM, Dunning DG, Reinhardt RA. Comparison of conventional periodontal maintenance versus scaling and root planing with subgingival minocycline. J Periodontol 2002: 73: 167-172.
136. Mestnik MJ, Feres M, Figueiredo LC, Duarte PM, Lira EAG, Faveri M. Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis. J Clin Periodontol 2010: 37: 353-365.
137. Million M, Lagier JC, Yahav D, Paul M. Gut bacterial microbiota and obesity. Clin Microbiol Infect 2013: 19: 305-313.
138. Miranda TS, Feres M, Perez-Chaparro PJ, Faveri M, Figueiredo LC, Tamashiro NS, Bastos MF, Duarte PM. Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1-year outcomes of a randomized placebo-controlled clinical trial. J Clin Periodontol 2014: 41: 890-899.
139. Mombelli A. Antimicrobial advances in treating periodontal diseases. In: Kinane DF, Mombelli A, editors. Frontiers of oral biology: periodontal disease. Basel: Karger AG, 2012: 133-148. ISSN 1320-2433.
140. Mombelli A, Almaghlouth A, Cionca N, Courvoisier DS, Giannopoulou C. Differential benefits of amoxicillin-metronidazole in different phases of periodontal therapy in a randomized controlled crossover clinical trial. J Periodontol 2015: 86: 367-375.
141. Mombelli A, Cionca N, Almaghlouth A, Décaillet F, Courvoisier DS, Giannopoulou C. Are there specific benefits of amoxicillin plus metronidazole in Aggregatibacter actinomycetemcomitans-associated periodontitis? Double-masked, randomized clinical trial of sfficacy and safety. J Periodontol 2013: 84: 715-724.
142. Morrison EC, Ramfjord SP, Hill RW. Short-term effects of initial, nonsurgical periodontal treatment (hygienic phase). J Clin Periodontol 1980: 7: 199-211.
143. Nakagawa T, Yamada S, Oosuka Y, Saito A, Hosaka Y, Ishikawa T, Okuda K. Clinical and microbiological study of local minocycline delivery (Periocline) following scaling and root planing in recurrent periodontal pockets. Bull Tokyo Dent Coll 1991: 32: 63-70.
144. Newman MG, Kornman KS, Doherty FM. A 6-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: clinical results. J Periodontol 1994: 65: 685-691.
145. Nibali L, Henderson B, Sadiq ST, Donos N. Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases. J Oral Microbiol 2014: 6: 22962.
146. Nociti FH Jr, Casati MZ, Duarte PM. Current perspective of the impact of smoking on the progression and treatment of periodontitis. Periodontol 2000 2015: 67: 187-210.
147. Olson MV. Human genetic individuality. Annu Rev Genomics Hum Genet 2012: 13: 1-27.
148. Oteo A, Herrera D, Figuero E, O'Connor A, González I, Sanz M. Azithromycin as an adjunct to scaling and root planing in the treatment of Porphyromonas gingivalis-associated periodontitis: a pilot study. J Clin Periodontol 2010: 37: 1005-1015.
149. Palmer AC, Kishony R. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat Rev 2013: 14: 243-248.
150. Palmer RM, Matthews JP, Wilson RF. Adjunctive systemic and locally delivered metronidazole in the treatment of periodontitis: a controlled clinical study. Br Dent J 1998: 184: 548-552.
151. Palmer RM, Matthews JP, Wilson RF. Non-surgical periodontal treatment with and without adjunctive metronidazole in smokers and non-smokers. J Clin Periodontol 1999: 26: 158-163.
152. Paolantonio M, D'Angelo M, Grassi RF, Perinetti G, Piccolomini R, Pizzo G, Annunziata M, D'Archivio D, D'Ercole S, Nardi G, Guida L. Clinical and microbiologic effects of subgingival controlled-release delivery of chlorhexidine chip in the treatment of periodontitis: a multicenter study. J Periodontol 2008: 79: 271-282.
153. Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu Rev Pathol 2012: 7: 99-122.
154. Pihlstrom B. Commentary: Treatment of periodontitis: key principles include removing subgingival bacterial deposits; providing a local environment and education to support good home care; providing regular professional maintenance. J Periodontol 2014: 85: 655-656.
155. Pihlstrom BL, McHugh RB, Oliphant TH, Ortiz-Campos C. Comparison of surgical and nonsurgical treatment of periodontal disease. A review of current studies and additional results after 61/2 years. J Clin Periodontol 1983: 10: 524-541.
156. Pihlstrom BL, Ortiz-Campos C, McHugh RB. A randomized four-year study of periodontal therapy. J Periodontol 1981: 52: 227-242.
157. Pozo-Rubio T, Olivares M, Nova E, De Palma G, Mujico JR, Ferrer MD, Marcos A, Sanz Y. Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol 2012: 2012: 1-12.
158. Preus HR, Gunleiksrud TM, Sandvik L, Gjermo P, Baelum V. A randomized, double-masked clinical trial comparing four periodontitis treatment strategies: 1-year clinical results. J Periodontol 2013: 84: 1075-1086.
159. Prosser JI, Bohannan BJM, Curtis TP, Ellis RJ, Firestone MK, Freckleton RP, Green JL, Green LE, Killham K, Lennon JJ, Osborn AM, Solan M, van der Gast CJ, Young JPW. The role of ecological theory in microbial ecology. Nat Rev Microbiol 2007: 5: 384-392.
160. Quirynen M, Teughels W, van Steenberghe D. Microbial shifts after subgingival debridement and formation of bacterial resistance when combined with local or systemic antimicrobials. Oral Dis 2003: 9(Suppl 1): 30-37.
161. Rabelo CC, Feres M, Gonçalves C, Figueiredo LC, Faveri M, Tu Y-K, Chambrone L. Systemic antibiotics in the treatment of aggressive periodontitis. A systematic review and a Bayesian Network meta-analysis. J Clin Periodontol 2015: 42: 647-657.
162. Rams TE, Degener JE, van Winkelhoff AJ. Prevalence of β-lactamase-producing bacteria in human periodontitis. J Periodontal Res 2013: 48: 493-499.
163. Rams TE, Degener JE, van Winkelhoff AJ. Antibiotic resistance in human chronic periodontitis microbiota. J Periodontol 2014: 85: 160-169.
164. Rams TE, Feik D, Young V, Hammond BF, Slots J. Enterococci in human periodontitis. Oral Microbiol Immunol 1992: 7: 249-252.
165. Ramseier CA, Suvan JE. Behaviour change counselling for tobacco use cessation and promotion of healthy lifestyles: a systematic review. J Clin Periodontol 2015: 42(Suppl 16): S47-S58.
166. Ready D, Pratten J, Roberts AP, Bedi R, Mullany P, Wilson M. Potential role of Veillonella spp. as a reservoir of transferable tetracycline resistance in the oral cavity. Antimicrob Agents Chemother 2006: 50: 2866-2868.
167. Renvert S, Persson GR. A systematic review on the use of residual probing depth, bleeding on probing and furcation status following initial periodontal therapy to predict further attachment and tooth loss. J Clin Periodontol 2002: 29(Suppl 3): 82-89.
168. Ribeiro ÉDP, Bittencourt S, Zanin ICJ, Bovi Ambrosano GM, Sallum EA, Nociti FH, Gonçalves RB, Casati MZ. Full-mouth ultrasonic debridement associated with amoxicillin and metronidazole in the treatment of severe chronic periodontitis. J Periodontol 2009: 80: 1254-1264.
169. Riep B, Purucker P, Bernimoulin JP. Repeated local metronidazole-therapy as adjunct to scaling and root planing in maintenance patients. J Clin Periodontol 1999: 26: 710-715.
170. Roberts AP, Mullany P. Oral biofilms: a reservoir of transferable, bacterial, antimicrobial resistance. Expert Rev Anti Infect Ther 2010: 8: 1441-1450.
171. Russell CD, Griffiths SJ, Baillie JK, Haas J. Stratified infection medicine: a call to arms. Lancet Infect Dis 2014: 14: 451.
172. Ryder MI. The influence of smoking on host responses in periodontal infections. Periodontol 2000 2007: 43: 267-277.
173. Sakellari D, Dimitra S, Ioannidis I, Ioannis I, Antoniadou M, Malama A, Slini T, Theodora S, Konstantinidis A, Antonis K. Clinical and microbiological effects of adjunctive, locally delivered chlorhexidine on patients with chronic periodontitis. J Int Acad Periodontol 2010: 12: 20-26.
174. Sampaio E, Rocha M, Figueiredo LC, Faveri M, Duarte PM, Gomes Lira EA, Feres M. Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 2011: 38: 838-846.
175. Sanz I, Alonso B, Carasol M, Herrera D, Sanz M. Nonsurgical treatment of periodontitis. J Evid Based Dent Pract 2012: 12: 76-86.
176. Sanz M, Teughels W. Innovations in non-surgical periodontal therapy: consensus report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008: 35: 3-7.
177. Schaefer AS, Bochenek G, Jochens A, Ellinghaus D, Dommisch H, Guzeldemir-Akcakanat E, Graetz C, Harks I, Jockel-Schneider Y, Weinspach K, Meyle J, Eickholz P, Linden GJ, Cine N, Nohutcu R, Weiss E, Houri-Haddad Y, Iraqi F, Folwaczny M, Noack B, Strauch K, Gieger C, Waldenberger M, Peters A, Wijmenga C, Yilmaz E, Lieb W, Rosenstiel P, Doerfer C, Bruckmann C, Erdmann J, König I, Jepsen S, Loos BG, Schreiber S. Genetic evidence for plasminogen as a shared genetic risk factor of coronary artery disease and periodontitis. Circ Cardiovasc Genet 2015: 8: 159-167.
178. Schaefer AS, Bochenek G, Manke T, Nothnagel M, Graetz C, Thien A, Jockel-Schneider Y, Harks I, Staufenbiel I, Wijmenga C, Eberhard J, Guzeldemir-Akcakanat E, Cine N, Folwaczny M, Noack B, Meyle J, Eickholz P, Trombelli L, Scapoli C, Nohutcu R, Bruckmann C, Doerfer C, Jepsen S, Loos BG, Schreiber S. Validation of reported genetic risk factors for periodontitis in a large-scale replication study. J Clin Periodontol 2013: 40: 563-572.
179. Schaefer A, Jepsen S, Loos BG. Periodontal genetics: a decade of genetic association studies mandates better study designs. J Clin Periodontol 2010: 38: 103-107.
180. Schaefer AS, Richter GM, Dommisch H, Reinartz M, Nothnagel M, Noack B, Laine ML, Folwaczny M, Groessner-Schreiber B, Loos BG, Jepsen S, Schreiber S. CDKN2BAS is associated with periodontitis in different European populations and is activated by bacterial infection. J Med Genet 2010: 48: 38-47.
181. Schaefer AS, Richter GM, Groessner-Schreiber B, Noack B, Nothnagel M, Mokhtari N-EE, Loos BG, Jepsen S, Schreiber S. Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet 2009: 5: e1000378.
182. Schaefer AS, Richter GM, Nothnagel M, Laine ML, Noack B, Glas J, Schrezenmeir J, Groessner-Schreiber B, Jepsen S, Loos BG, Schreiber S. COX-2 is associated with periodontitis in Europeans. J Dent Res 2010: 89: 384-388.
183. Schaefer AS, Richter GM, Nothnagel M, Laine ML, Ruhling A, Schafer C, Cordes N, Noack B, Folwaczny M, Glas J, Dorfer C, Dommisch H, Groessner-Schreiber B, Jepsen S, Loos BG, Schreiber S. A 3′ UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun 2010: 11: 45-54.
184. Schaefer AS, Richter GM, Nothnagel M, Manke T, Dommisch H, Jacobs G, Arlt A, Rosenstiel P, Noack B, Groessner-Schreiber B, Jepsen S, Loos BG, Schreiber S. A genome-wide association study identifies GLT6D1 as a susceptibility locus for periodontitis. Hum Mol Genet 2010: 19: 553-562.
185. Schmidt C. Mental health: thinking from the gut. Nature 2015: 518: S12-S15.
186. Sekirov I, Finlay BB. The role of the intestinal microbiota in enteric infection. J Physiol 2009: 587: 4159-4167.
187. Sellitto M, Bai G, Serena G, Fricke WF, Sturgeon C, Gajer P, White JR, Koenig SSK, Sakamoto J, Boothe D, Gicquelais R, Kryszak D, Puppa E, Catassi C, Ravel J, Fasano A. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS ONE 2012: 7: e33387.
188. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev 2008: 8: 349-361.
189. Serrano C, Torres N, Valdivieso C, Castaño C, Barrera M, Cabrales A. Antibiotic resistance of periodontal pathogens obtained from frequent antibiotic users. Acta Odontol Latinoam 2009: 22: 99-104.
190. Sgolastra F, Gatto R, Petrucci A, Monaco A. Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontol 2012: 83: 1257-1269.
191. Sgolastra F, Petrucci A, Gatto R, Monaco A. Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-Analysis. J Periodontol 2012: 83: 731-743.
192. Sharon I, Morowitz MJ, Thomas BC, Costello EK, Relman DA, Banfield JF. Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization. Genome Res 2013: 23: 111-120.
193. Shimizu S, Momozawa Y, Takahashi A, Nagasawa T, Ashikawa K, Terada Y, Izumi Y, Kobayashi H, Tsuji M, Kubo M, Furuichi Y. A genome-wide association study of periodontitis in a japanese population. J Dent Res 2015: 94: 555-561.
194. Silva MP, Feres M, Oliveira Sirotto TA, Silva Soares GM, Velloso Mendes JA, Faveri M, Figueiredo LC. Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 2011: 38: 828-837.
195. Silva-Senem MXE, Heller D, Varela VM, Torres MCB, Feres-Filho EJ, Colombo APV. Clinical and microbiological effects of systemic antimicrobials combined to an anti-infective mechanical debridement for the management of aggressive periodontitis: a 12-month randomized controlled trial. J Clin Periodontol 2013: 40: 242-251.
196. Siqueira JF, Fouad AF, Rôças IN. Pyrosequencing as a tool for better understanding of human microbiomes. J Oral Microbiol 2012: 4: 10743. DOI: 10.3402/jom.v4i0.10743.
197. Slots J. Systemic antibiotics in periodontics. J Periodontol 2004: 75: 1553-1565.
198. Söder DB, Nedlich U, Jin LJ. Longitudinal effect of non-surgical treatment and systemic metronidazole for 1 week in smokers and non-smokers with refractory periodontitis: a 5-year study. J Periodontol 1999: 70: 761-771.
199. Sommer MOA, Dantas G, Church GM. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009: 325: 1128-1131.
200. Song X, Sun J, Mikalsen T, Roberts AP, Sundsfjord A. Characterisation of the plasmidome within Enterococcus faecalis isolated from marginal periodontitis patients in Norway. PLoS ONE 2013: 8: e62248.
201. Soskolne WA, Chajek T, Flashner M, Landau I, Stabholtz A, Kolatch B, Lerner EI. An in vivo study of the chlorhexidine release profile of the PerioChipTM in the gingival crevicular fluid, plasma and urine. J Clin Periodontol 1998: 25: 1017-1021.
202. Teughels W, Dhondt R, Dekeyser C, Quirynen M. Treatment of aggressive periodontitis. Periodontol 2000 2014: 65: 107-133.
203. Thomson WM, Broadbent JM, Welch D, Beck JD, Poulton R. Cigarette smoking and periodontal disease among 32-year-olds: a prospective study of a representative birth cohort. J Clin Periodontol 2007: 34: 828-834.
204. Thomson WM, Shearer DM, Broadbent JM, Foster Page LA, Poulton R. The natural history of periodontal attachment loss during the third and fourth decades of life. J Clin Periodontol 2013: 40: 672-680.
205. Timmerman MF, Van der Weijden GA, Van Steenbergen TJ, Mantel MS, De Graaff J, Van der Velden U. Evaluation of the long-term efficacy and safety of locally-applied minocycline in adult periodontitis patients. J Clin Periodontol 1996: 23: 707-716.
206. Tomasi C, Wennström JL. Locally delivered doxycycline improves the healing following non-surgical periodontal therapy in smokers. J Clin Periodontol 2004: 31: 589-595.
207. Tomasi C, Wennström JL. Locally delivered doxycycline as an adjunct to mechanical debridement at retreatment of periodontal pockets: outcome at furcation sites. J Periodontol 2011: 82: 210-218.
208. Tonetti MS, Cortellini P, Carnevale G, Cattabriga M, de Sanctis M, Pini Prato GP. A controlled multicenter study of adjunctive use of tetracycline periodontal fibers in mandibular class II furcations with persistent bleeding. J Clin Periodontol 1998: 25: 728-736.
209. Tonetti MS, Lang NP, Cortellini P, Suvan JE, Eickholz P, Fourmousis I, Topoll H, Vangsted T, Wallkamm B, on behalf of the European Research Group on Periodontology (ERGOPerio). Effects of a single topical doxycycline administration adjunctive to mechanical debridement in patients with persistent/recurrent periodontitis but acceptable oral hygiene during supportive periodontal therapy. J Clin Periodontol 2012: 39: 475-482.
210. Toprak E, Veres A, Michel J-B, Chait R, Hartl DL, Kishony R. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet 2011: 44: 101-105.
211. Vaarala O. Human intestinal microbiota and type 1 diabetes. Curr Diab Rep 2013: 13: 601-607.
212. Van der Velden U, Varoufaki A, Hutter JW, Xu L, Timmerman MF, van Winkelhoff AJ, Loos BG. Effect of smoking and periodontal treatment on the subgingival microflora. J Clin Periodontol 2003: 30: 603-610.
213. Van Dyke TE, Offenbacher S, Braswell L, Lessem J. Enhancing the value of scaling and root-planing: Arestin clinical trial results. J Int Acad Periodontol 2002: 4: 72-76.
214. Varela VM, Heller D, Silva-Senem MX, Torres MCMB, Colombo APV, Feres-Filho EJ. Systemic antimicrobials adjunctive to a repeated mechanical and antiseptic therapy for aggressive periodontitis: a 6-month randomized controlled trial. J Periodontol 2011: 82: 1121-1130.
215. Veloo ACM, Seme K, Raangs E, Rurenga P, Singadji Z, Wekema-Mulder G, van Winkelhoff AJ. Antibiotic susceptibility profiles of oral pathogens. Int J Antimicrob Agents 2012: 40: 450-454.
216. Villedieu A, Diaz-Torres ML, Hunt N, McNab R, Spratt DA, Wilson M, Mullany P. Prevalence of tetracycline resistance genes in oral bacteria. Antimicrob Agents Chemother 2003: 47: 878-882.
217. Villedieu A, Diaz-Torres ML, Roberts AP, Hunt N, McNab R, Spratt DA, Wilson M, Mullany P. Genetic basis of erythromycin resistance in oral bacteria. Antimicrob Agents Chemother 2004: 48: 2298-2301.
218. Walker WA. Initial intestinal colonization in the human infant and immune homeostasis. Ann Nutr Metab 2013: 63: 8-15.
219. Walker CB, Gordon JM, Magnussen I, Clark WB. A role for antibiotics in the treatment of refractory periodontitis. J Periodontol 1993: 64: 772-781.
220. Walker C, Karpinia K. Rationale for use of antibiotics in periodontics. J Periodontol 2002: 73: 1188-1196.
221. Walker CB, Karpinia K, Baehni P. Chemotherapeutics: antibiotics and other antimicrobials. Periodontol 2000 2004: 36: 146-165.
222. Walker MC, Thuronyi BW, Charkoudian LK, Lowry B, Khosla C, Chang MCY. Expanding the fluorine chemistry of living systems using engineered polyketide synthase pathways. Science 2013: 341: 1089-1094.
223. Wållberg M, Cooke A. Immune mechanisms in type 1 diabetes. Trends Immunol 2013: 34: 583-591.
224. Warburton PJ, Palmer RM, Munson MA, Wade WG. Demonstration of in vivo transfer of doxycycline resistance mediated by a novel transposon. Int J Antimicrob Agents 2007: 60: 973-980.
225. Wennström JL, Newman HN, MacNeill SR, Killoy WJ, Griffiths GS, Gillam DG, Krok L, Needleman IG, Weiss G, Garrett S. Utilisation of locally delivered doxycycline in non-surgical treatment of chronic periodontitis. J Clin Periodontol 2001: 28: 753-761.
226. Winkel EG, van Winkelhoff AJ, Timmerman MF, Van der Velden U, Van der Weijden GA. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol 2001: 28: 296-305.
227. van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, van der Reijden WA. Smoking affects the subgingival microflora in periodontitis. J Periodontol 2001: 72: 666-671.
228. van Winkelhoff AJ, Herrera D, Oteo A, Sanz M. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in the Netherlands and Spain. J Clin Periodontol 2005: 32: 893-898.
229. van Winkelhoff AJ, Tijhof CJ, De Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol 1992: 63: 52-63.
230. Wong MY, Lu CL, Liu CM, Hou LT, Chang WK. Clinical response of localized recurrent periodontitis treated with scaling, root planing, and tetracycline fiber. J Formos Med Assoc 1998: 97: 490-497.
231. Wrighton KC, Thomas BC, Sharon I, Miller CS, Castelle CJ, VerBerkmoes NC, Wilkins MJ, Hettich RL, Lipton MS, Williams KH, Long PE, Banfield JF. Fermentation, hydrogen, and sulfur metabolism in multiple uncultivated bacterial phyla. Science 2012: 337: 1661-1665.
232. Wu T, Cen L, Kaplan C, Zhou X, Lux R, Shi W, He X. Cellular components mediating coadherence of candida albicans and Fusobacterium nucleatum. J Dent Res 2015: 94: 1432-1438.
233. Xajigeorgiou C, Sakellari D, Slini T, Baka A, Konstantinidis A. Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. J Clin Periodontol 2006: 33: 254-264.
234. Xu Z-Z, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji R-R. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 2010: 16: 592-597.
235. Yalcin F, Demirel K, Onan U. Evaluation of adjunctive tetracycline fiber therapy with scaling and root planing: short-term clinical results. Periodontal Clin Investig 1999: 21: 23-27.
236. Yek EC, Cintan S, Topcuoglu N, Kulekci G, I˙ssever H, Kantarci A. Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. J Periodontol 2010: 81: 964-974.
237. Yilmaz S, Kut B, Gursoy H, Eren-Kuru B, Noyan U, Kadir T. Er:YAG laser versus systemic metronidazole as an adjunct to nonsurgical periodontal therapy: a clinical and microbiological study. Photomed Laser Surg 2012: 39: 526-536.
238. Zandbergen D, Slot DE, Cobb CM, Van der Weijden FA. The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review. J Periodontol 2013: 84: 332-351.
239. Zarco MF, Vess TJ, Ginsburg GS. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 2012: 18: 109-120.
240. Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE 2013: 8: e71108.
241. Zhou J, He Z, Yang Y, Deng Y, Tringe SG, Timmerman MF. High-throughput metagenomic technologies for complex microbial community analysis: open and closed formats. mBio 2015: 6: e02288-14.